Page last updated: 2024-08-22

clodronic acid and alpha-Galactosidase A Deficiency

clodronic acid has been researched along with alpha-Galactosidase A Deficiency in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, SH; Cherry, M; Desnick, RJ; Goldberg, MA; Hempel, D; Ioannou, YA; Li, C; van Rooijen, N; Yew, NS; Zhu, Y; Ziegler, RJ	1

Other Studies

1 other study(ies) available for clodronic acid and alpha-Galactosidase A Deficiency

Article	Year
Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease. Human gene therapy, 2002, May-20, Volume: 13, Issue:8 Topics: Adenoviridae; alpha-Galactosidase; Animals; Clodronic Acid; Dose-Response Relationship, Drug; Fabry Disease; Female; gamma-Globulins; Genetic Therapy; Genetic Vectors; Humans; Kupffer Cells; Liver; Mice; Mice, Inbred BALB C; Transduction, Genetic	2002

Article

Year

Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease.

Human gene therapy, 2002, May-20, Volume: 13, Issue:8

Topics: Adenoviridae; alpha-Galactosidase; Animals; Clodronic Acid; Dose-Response Relationship, Drug; Fabry Disease; Female; gamma-Globulins; Genetic Therapy; Genetic Vectors; Humans; Kupffer Cells; Liver; Mice; Mice, Inbred BALB C; Transduction, Genetic

2002